Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. For the current quarter, Canopy Growth is expected ...

Its third quarter results are in the books and Beacon Securities analyst Doug Cooper still thinks there is money to be made ...

Short-selling has been rampant in the cannabis sector, sometimes facilitated by company insiders lending their own shares to ...

In a report released on November 8, Lisa Lewandowski from Bank of America Securities reiterated a Sell rating on Canopy Growth (CGC – Research Report), with a price target of C$ ... dampen investor ...

It has experienced a hiccup, but the company is still on the right path. That’s the opinion of Roth MKM analyst Bill Kirk on ...

Canopy Growth's revenue and EBITDA have been disappointing, and analysts' projections for FY25 and FY26 remain weak. Read why ...

This past week, the Toronto Stock Exchange (TSE) experienced a mix of gains and ... which soared over 7% on news of expanding ...

The Dow crossed 44,0000 for the first time ever as stocks were on track for their best week in a year on optimism that ...

Baxter International shares fell after it posted a drop in third-quarter earnings. Shares of cannabis producer Canopy Growth fell after a slowdown in adult marijuana use in Canada weighed on earnings.

My name is Nicole, and I will be your conference operator today. I would like to welcome you to Canopy Growth's second ...

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Canopy saw a significant decline in Canadian adult-use cannabis, where revenue fell 24% to C$18.4 million. This offset the 16% gain from Canadian medical cannabis which reached C$18.7 million, and ...